Cargando…
Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
OBJECTIVE: The aim of the study was to describe the course of IgG/IgA immune response in women immunized with bivalent vaccine and in women non-vaccinated with HPV infection, as well as evaluating the cross-protection against non-vaccine HPV types. METHODS: Serum and cervical mucus samples were coll...
Autores principales: | Costa, Ana Paula, Giraldo, Paulo César, Cobucci, Ricardo Ney, Consolaro, Márcia Lopes, Souza, Raquel Pantarotto, Canário, Luanda Barbara, Machado, Paula Renata, Martins, Rand Randall, Baptista, Pedro Vieira, Jr, José Eleutério, Gonçalves, Ana Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779425/ https://www.ncbi.nlm.nih.gov/pubmed/32986383 http://dx.doi.org/10.31557/APJCP.2020.21.9.2799 |
Ejemplares similares
-
Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix
por: Costa, Ana Paula Ferreira, et al.
Publicado: (2018) -
Transient IgA, steady IgG?
por: Berthold, Dorothée L., et al.
Publicado: (2020) -
IgA nephropathy in IgG kappa multiple myeloma
por: Couto, Maria Eduarda, et al.
Publicado: (2021) -
IgG deposition in IgA nephropathy patients
por: Nasri, Hamid
Publicado: (2013) -
Linear IgA and IgG bullous dermatosis
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2016)